Sepsis Diagnostics Market: Global Industry Trends, Growth Opportunities, and Forecast
The Sepsis Diagnostics Market is expanding as healthcare providers increasingly focus on early detection, rapid pathogen identification, and effective management of sepsis.
According to Market Research Future, the global market was valued at USD 0.85 billion in 2025 and is projected to reach USD 1.69 billion by 2035, registering a CAGR of 7.1% during 2026–2035.
The growing global burden of sepsis, hospital-acquired infections, antimicrobial resistance, and the need for rapid diagnosis are key factors supporting market growth. Traditional blood culture methods can require significant time for pathogen identification, encouraging healthcare organizations to adopt molecular diagnostics, immunoassays, and automated testing technologies.
Molecular diagnostics represented approximately 36% of the market in 2025, while assays and reagents accounted for roughly 52% of the product segment. North America held the largest regional share at approximately 38%, whereas Asia-Pacific is projected to be the fastest-growing region.
Increasing investments in hospital laboratory infrastructure and the adoption of advanced diagnostic platforms are expected to create additional opportunities for market participants through 2035.